Berit Johansen (B Johansen)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Top Venues

Nature biotechnology

Arthritis research & therapy

Norwegian University of Science and Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Norwegian University of Science and Technology Oct 01 1985 - Mar 16 1990

Norway

PHD :: Department of Chemistry

Publications

Vinzent Kevin Ortner, Berit Johansen, Kim Kilov, Alejandro Castillo Mondragón, Tore Duvold, Jesper Kihl, Felicity J Ashcroft, Astrid Jullumstrø Feuerherm, Charlotte Amalie Pind Laugesen, Maiken Lise Marcker Espersen, Ionela Manole, Ari Páll Isberg, Anders Daniel Andersen, Elin Rakvaag, John Robert Zibert, Merete Haedersdal
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A 2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial. BMJ open 12 (10) (2022)
A J Feuerherm, E A Dennis, Berit Johansen
Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis. Arthritis research & therapy 21 (1) (2019)
Knut J Egelie, Gregory D Graff, Sabina P Strand, Berit Johansen
The emerging patent landscape of CRISPR-Cas gene editing technology. Nature biotechnology 34 (10) (2018)